Opus Genetics

IRDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$302.191 M

$3.66 -1.61%

Close of 7 Aug 2026

Revenue

$14.2M

#3096 by revenue

Earnings

-$49.6M

Loss-making

Shares outstanding

83,195,823

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#232Turn TherapeuticsTTRX$310.1M
#233Amarin Corp Plc\UkAMRN$303.3M
#234Opus GeneticsIRD$302.2M
#235Vanda PharmaceuticalsVNDA$300.7M
#236Zentalis PharmaceuticalsZNTL$300.4M

Where these numbers come from

Share counts and financials for Opus Genetics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.